New HER2-directed therapies for breast cancer: Commentary re: C. I. Spiridon et al., Targeting multiple HER-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)1699-1701
Number of pages3
JournalClinical Cancer Research
Issue number6
StatePublished - Jun 25 2002

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this